Clinical Trial Update: Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating pharmacokinetics, safety, and tolerability of ferric maltol at three dose levels in pediatric subjects with iron deficiency and anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia in Children
• Iron Deficiency in Children

Drugs mentioned

• Ferric Maltol (ferric maltol)

Snippet

Sponsor: Shield Therapeutics | Conditions: Iron Deficiency, Anaemia in Children, Iron-Deficiency | Phase 1 | Status: COMPLETED | Results posted: 2020-06-02